Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347503 · ClinicalTrials.gov registry record · Phase 4
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00347503: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00347503 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00347503, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Evaluation of the aqueous concentrations of 2 topical NSAIDS as well as the PGE2 inhibition in human patients.
Interventions
- DRUG ketorolac 0.4%, bromfenac 0.09%
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00347503 record still lists
NCT00347503 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which ketorolac 0.4%, bromfenac 0.09% is the first listed.
NCT00347503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00347503 about?
NCT00347503 is a clinical study titled "Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients". Evaluation of the aqueous concentrations of 2 topical NSAIDS as well as the PGE2 inhibition in human patients.
What is the current status of trial NCT00347503?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00347503?
The interventions under investigation include: ketorolac 0.4%, bromfenac 0.09% (DRUG).
Who is sponsoring clinical trial NCT00347503?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.